Radiotherapy With or Without Surgery for Maxillary Sinus Squamous Cell Carcinoma Should the Clinical N0 Neck be Treated?

被引:13
作者
Hinerman, Russell W. [1 ]
Indelicato, Daniel J. [1 ]
Morris, Christopher G. [1 ]
Kirwan, Jessica M. [1 ]
Werning, John W. [2 ]
Vaysberg, Mikhail [2 ]
Mendenhall, William M. [1 ]
机构
[1] Univ Florida, Coll Med, Dept Radiat Oncol, Gainesville, FL USA
[2] Univ Florida, Coll Med, Dept Otolaryngol, Gainesville, FL USA
来源
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS | 2011年 / 34卷 / 05期
关键词
squamous cell carcinoma; maxillary sinus; radiotherapy; surgery; head and neck cancer; LONG-TERM OUTCOMES; POSTOPERATIVE RADIOTHERAPY; RADIATION-THERAPY; NECK IRRADIATION; CANCER; CHEMOTHERAPY; MANAGEMENT; RISK;
D O I
10.1097/COC.0b013e3181f942c7
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objectives: Maxillary sinus squamous cell carcinoma is commonly diagnosed at an advanced stage and treated using radiotherapy, with or without surgical resection. Methods: Fifty-four patients with maxillary sinus squamous cell carcinoma were treated from 1969 to 2006, using radiotherapy, with or without surgical resection. Fifty-two (96%) patients had American Joint Committee on Cancer stages III to IV disease, and 45 (83%) patients had N0 neck disease. Results: Five-year local control (LC) rates by T-stage were 63% for T2/T3; and 43% for T4. Five-year LC rates for patients treated with radiotherapy preoperatively, postoperatively, and definitively were 61%, 65%, and 37%, respectively. Initially, overall 5-year LC, neck control, and local-regional control were 49%, 82%, and 45%, respectively. The ultimate 5-year LC, neck control, and local regional control after salvage of failures were 51%, 87%, and 50%, respectively. The overall 5-year cause-specific survival was 41%. Thirty-three percent of patients had a severe complication. Conclusions: Radiotherapy, with or without surgical resection, remains an effective tool in treating patients with this disease. LC, cause-specific survival, and complication rates need significant improvement. Treatment details and recommendations are discussed herein.
引用
收藏
页码:483 / 487
页数:5
相关论文
共 27 条
  • [1] [Anonymous], 2002, AJCC CANC STAG MAN
  • [2] Does altered fractionation influence the risk of radiation-induced optic neuropathy?
    Bhandare, N
    Monroe, AT
    Morris, CG
    Bhatti, MT
    Mendenhall, WM
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2005, 62 (04): : 1070 - 1077
  • [3] Carcinoma of paranasal sinuses: Long-term outcomes with radiotherapy
    Blanco, AI
    Chao, KSC
    Ozyigit, G
    Adli, M
    Thorstad, WL
    Simpson, JR
    Spector, GJ
    Haughey, B
    Perez, CA
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2004, 59 (01): : 51 - 58
  • [4] Postoperative radiotherapy for maxillary sinus cancer: Long-term outcomes and toxicities of treatment
    Bristol, Ian J.
    Ahamad, Anesa
    Garden, Adam S.
    Morrison, William H.
    Hanna, Ehab Y.
    Papadimitrakopoulou, Vassiliki A.
    Rosenthal, David I.
    Ang, K. Kian
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2007, 68 (03): : 719 - 730
  • [5] Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck
    Cooper, JS
    Pajak, TF
    Forastiere, AA
    Jacobs, J
    Campbell, BH
    Saxman, SB
    Kish, JA
    Kim, HE
    Cmelak, AJ
    Rotman, M
    Machtay, M
    Ensley, JF
    Chao, KSC
    Schultz, CJ
    Lee, N
    Fu, KK
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (19) : 1937 - 1944
  • [6] GIRI SPG, 1992, CANCER, V69, P657, DOI 10.1002/1097-0142(19920201)69:3<657::AID-CNCR2820690310>3.0.CO
  • [7] 2-7
  • [8] Hayashi T, 2001, CANCER-AM CANCER SOC, V92, P1495, DOI 10.1002/1097-0142(20010915)92:6<1495::AID-CNCR1474>3.0.CO
  • [9] 2-P
  • [10] ISAACS JH, 1990, AM SURGEON, V56, P327